Antibiotics for Acinetobacter baumannii

Treatment may involve a single active antibiotic or a combination chosen by an infectious-diseases or microbiology team. Do not use leftover antibiotics, share a prescription, or stop treatment early unless the treating team changes the plan.

Acinetobacter baumannii is a bacterium that can cause pneumonia, bloodstream infection, wound infection, or infection around medical devices, particularly in healthcare settings. It can also be found on a person without causing illness; this is called colonisation and does not automatically require antibiotics.

A laboratory culture identifies the organism, and susceptibility testing shows which antibiotics can inhibit it. Clinicians interpret those findings alongside the sample site, symptoms, organ function, allergies, pregnancy status, and severity of illness. A result from sputum or a wound must be matched to the clinical picture rather than treated in isolation.

Take each dose at the prescribed time and tell the care team promptly if a dose is missed or vomiting prevents it from staying down. Report previous antibiotic allergies and provide a complete medicine list. Hospital treatment may require intravenous medicine, monitoring of kidney or liver function, and removal or replacement of an infected device when appropriate.

Hand hygiene helps limit spread. In hospital, follow instructions about gowns, gloves, room precautions, and wound or device care. At home, keep dressings clean as directed, avoid sharing towels or personal care items, and do not pressure clinicians for an antibiotic before cultures clarify whether bacterial treatment is needed.

Seek urgent help for difficulty breathing, blue or grey lips, new confusion, fainting, severe weakness, rapidly worsening fever or chills, very low urine output, or cold and mottled skin. These features can accompany serious infection and require immediate assessment.

Contact the prescribing team promptly for a spreading rash, facial or throat swelling, wheezing, severe or persistent diarrhoea, repeated vomiting, yellowing of the skin or eyes, or a marked reduction in urination. Do not restart an antibiotic that previously caused a severe reaction.

Ask whether the culture represents infection or colonisation, which susceptibility result supports the chosen medicine, how it will be given, what monitoring is planned, and which adverse effects need immediate attention. You can also ask when cultures or symptoms will be reviewed and whether a device or wound needs additional treatment.